KAMIYA BIOMEDICAL COMPANY

KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California, with the purpose of supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets.
The companys first products were the cutting edge protein kinase inhibitors staurosporine and K252a for signal transduction research. In 1990, KAMIYA became the first company to introduce anti-Fas monoclonal antibodies to the U.S. research community. Since then, KAMIYA has become a leader in supplying quality apoptosis research products to the global market.

Contact Details: 12779 Gateway Drive Seattle Washington 98168 United States of America Tel: (206) 575-8068 Fax: (206) 575-8094 Email: webmaster@kamiyabiomedical.com WWW: www.kamiyabiomedical.com/

Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 564 times since April 2007, the link to the organisation's website has been followed 67 times

Recent Search Terms used to find this page: kohji kamiya | cutting edge biomed companies | Kamiya Biomedical Company | Kamiya Biomedical Company | bio medical company | bio medical company | kamiya biomedical distributor | kamiya biomedical | company profile kamiya biomedical | KAMIYA BIOMEDICAL COMPANY | .

Search for more companies in Seattle

Search for more companies in Washington

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for KAMIYA BIOMEDICAL COMPANY